drugmakers

Donald Trump's vaccine plan allegedly requires millions of individual shots using methods not utilized for decades. The primary obstacles posed to this proposed order include logistical challenges affecting U.S. parents, health providers, and drugmakers.

AstraZeneca Plc has explored an acquisition of Bristol Myers Squibb Co., in a megadeal that would create one of the world’s largest drugmakers.

India’s second-largest money manager is optimistic about banks, oil refiners, power utilities, and drugmakers, anticipating demand growth despite global volatility. The fund manager believes these sectors are well-positioned to benefit from favorable market conditions.

Biotech deals have surged to a record high as Big Pharma experiences fear of missing out, driven by the impending expiration of patents on profitable drugs, prompting pharmaceutical companies to seek new blockbuster medicines.

President Trump claimed TrumpRx is the most significant healthcare development in decades. However, an NPR analysis reveals that drugmakers are only providing discounts on a limited number of their medications.

President Trump promoted TrumpRx as a major healthcare initiative for cheaper drugs, but an NPR analysis reveals that drug manufacturers are only offering discounts on a limited number of medications.

Drugmakers are developing a potential new vaccine to prevent Lyme disease, a tick-borne illness. The article explores how the vaccine might be received amid current vaccine skepticism, particularly among hunters.

Drugmakers are developing a potential new Lyme disease vaccine to prevent tick-borne illness. The article explores how the vaccine might be received in the context of vaccine skepticism, particularly among hunters.

The Trump administration proposed a policy to prevent drugmakers from evading Medicare price negotiations by adding active ingredients to drugs. The policy aims to finalize the selection of 20 drugs and biologics for negotiation by February 1, 2027, with negotiated prices taking effect in 2029. Medicare typically waits 7 to 11 years after FDA approval before negotiating prices, with biologics requiring longer delays.

A report found that drugmakers increased prices on hundreds of drugs despite President Trump's TrumpRx initiative aimed at reducing costs. Trump had announced the program in February 2020, but the analysis revealed ongoing price hikes by pharmaceutical companies.